The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the Bloomberg Global Aggregate ...

Featured here, the Cash Flow Statement for Pabrik Kertas Tjiwi Kimia Tbk, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing ...

A randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary ...

International non-profit research company IAVI has dosed the first patients in its Phase IIb trial of tuberculosis (TB) vaccine, which, if approved, could be the second to be cleared in more than ...

Credit: Shutterstock / Creativa Images. International non-profit research company IAVI has dosed the first patients in its Phase IIb trial of tuberculosis (TB) vaccine, which, if approved, could be ...

Mumbai, 25 March 2024: The clinical trials of the novel tuberculosis vaccine MTBVAC began in India on Sunday, marking a “giant step” forward in the fight against one of the world’s deadliest ...

BCG, the only TB vaccine currently used for prevention is ... have the ability to cause disease in healthy people. A phase 1a trial showed that MTBVAC demonstrated a similar safety profile to ...